NYSEAMERICAN:MLSS

Milestone Scientific Competitors

$3.68

-0.03 (-0.81 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$3.37

Now: $3.68▼

$3.85

50-Day Range

$1.47

MA: $1.89▼

$2.31

52-Week Range

$0.85

Now: $3.68▼

$4.40

Volume545,388 shs

Average Volume835,781 shs

Market Capitalization$234.39 million

P/E RatioN/A

Dividend YieldN/A

Beta1.54

Milestone Scientific (NYSEAMERICAN:MLSS) Vs. SIEN, IVC, LAKE, UEEC, NTRB, and SRGA

Should you be buying MLSS stock or one of its competitors? Companies in the industry of "surgical appliances & supplies" are considered alternatives and competitors to Milestone Scientific, including Sientra (SIEN), Invacare (IVC), Lakeland Industries (LAKE), United Health Products (UEEC), Nutriband (NTRB), and Surgalign (SRGA).

Milestone Scientific vs. Sientra Stock

Sientra (NASDAQ:SIEN) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Sientra and Milestone Scientific's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sientra	$83.70 million	4.29	$-106,820,000.00	($2.29)	-3.11
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00

Milestone Scientific has lower revenue, but higher earnings than Sientra. Milestone Scientific is trading at a lower price-to-earnings ratio than Sientra, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Sientra has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

71.0% of Sientra shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 2.8% of Sientra shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Sientra and Milestone Scientific's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sientra	-123.88%	-174.05%	-38.97%
Milestone Scientific	-165.06%	-104.43%	-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Sientra and Milestone Scientific, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sientra	0	0	6	0	3.00
Milestone Scientific	0	1	1	0	2.50

Sientra currently has a consensus price target of $8.20, indicating a potential upside of 15.17%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Sientra's stronger consensus rating and higher possible upside, research analysts clearly believe Sientra is more favorable than Milestone Scientific.

Summary

Sientra beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

Milestone Scientific vs. Invacare Stock

Invacare (NYSE:IVC) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Invacare and Milestone Scientific's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Invacare	$927.96 million	0.34	$-53,330,000.00	($1.06)	-8.58
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00

Milestone Scientific has lower revenue, but higher earnings than Invacare. Milestone Scientific is trading at a lower price-to-earnings ratio than Invacare, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Invacare has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 3.2% of Invacare shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Invacare and Milestone Scientific's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Invacare	-4.87%	-8.76%	-3.07%
Milestone Scientific	-165.06%	-104.43%	-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Invacare and Milestone Scientific, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Invacare	0	0	2	0	3.00
Milestone Scientific	0	1	1	0	2.50

Invacare currently has a consensus price target of $14.00, indicating a potential upside of 53.85%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Invacare's stronger consensus rating and higher possible upside, research analysts clearly believe Invacare is more favorable than Milestone Scientific.

Summary

Invacare beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

Milestone Scientific vs. Lakeland Industries Stock

Lakeland Industries (NASDAQ:LAKE) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Lakeland Industries and Milestone Scientific's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lakeland Industries	$107.81 million	2.17	$3.28 million	$0.45	64.78
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00

Lakeland Industries has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Lakeland Industries has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

70.8% of Lakeland Industries shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 4.9% of Lakeland Industries shares are owned by insiders. Comparatively, 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Lakeland Industries and Milestone Scientific's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lakeland Industries	18.93%	28.75%	24.67%
Milestone Scientific	-165.06%	-104.43%	-67.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Lakeland Industries and Milestone Scientific, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lakeland Industries	0	0	3	0	3.00
Milestone Scientific	0	1	1	0	2.50

Lakeland Industries currently has a consensus price target of $31.3333, indicating a potential upside of 7.49%. Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Lakeland Industries.

Summary

Lakeland Industries beats Milestone Scientific on 10 of the 14 factors compared between the two stocks.

Milestone Scientific vs. United Health Products Stock

United Health Products (OTCMKTS:UEEC) and Milestone Scientific (NYSEAMERICAN:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Profitability

This table compares United Health Products and Milestone Scientific's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United Health Products	N/A	N/A	-8,666.57%
Milestone Scientific	-165.06%	-104.43%	-67.75%

Risk and Volatility

United Health Products has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Insider and Institutional Ownership

0.6% of United Health Products shares are owned by institutional investors. Comparatively, 11.6% of Milestone Scientific shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for United Health Products and Milestone Scientific, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United Health Products	0	0	0	0	N/A
Milestone Scientific	0	1	1	0	2.50

Milestone Scientific has a consensus price target of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, analysts clearly believe Milestone Scientific is more favorable than United Health Products.

Earnings & Valuation

This table compares United Health Products and Milestone Scientific's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United Health Products	N/A	N/A	$-6,600,000.00	N/A	N/A
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00

United Health Products has higher earnings, but lower revenue than Milestone Scientific.

Summary

Milestone Scientific beats United Health Products on 7 of the 11 factors compared between the two stocks.

Milestone Scientific vs. Nutriband Stock

Milestone Scientific (NYSEAMERICAN:MLSS) and Nutriband (OTCMKTS:NTRB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Milestone Scientific and Nutriband's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-165.06%	-104.43%	-67.75%
Nutriband	-263.80%	-53.69%	-32.84%

Insider and Institutional Ownership

11.6% of Milestone Scientific shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by company insiders. Comparatively, 46.1% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Milestone Scientific and Nutriband, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0	1	1	0	2.50
Nutriband	0	0	0	0	N/A

Milestone Scientific currently has a consensus target price of $4.00, indicating a potential upside of 8.70%. Given Milestone Scientific's higher possible upside, equities analysts plainly believe Milestone Scientific is more favorable than Nutriband.

Valuation and Earnings

This table compares Milestone Scientific and Nutriband's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00
Nutriband	$370,000.00	524.24	$-2,720,000.00	($0.37)	-83.78

Nutriband has lower revenue, but higher earnings than Milestone Scientific. Nutriband is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Summary

Milestone Scientific beats Nutriband on 7 of the 12 factors compared between the two stocks.

Milestone Scientific vs. Surgalign Stock

Milestone Scientific (NYSEAMERICAN:MLSS) and Surgalign (NASDAQ:SRGA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Insider & Institutional Ownership

11.6% of Milestone Scientific shares are owned by institutional investors. Comparatively, 53.5% of Surgalign shares are owned by institutional investors. 27.3% of Milestone Scientific shares are owned by company insiders. Comparatively, 3.7% of Surgalign shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Milestone Scientific has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, Surgalign has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500.

Profitability

This table compares Milestone Scientific and Surgalign's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-165.06%	-104.43%	-67.75%
Surgalign	-56.07%	-101.34%	-18.44%

Earnings & Valuation

This table compares Milestone Scientific and Surgalign's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.38 million	27.97	$-7,520,000.00	($0.16)	-23.00
Surgalign	$308.38 million	0.60	$-211,640,000.00	($0.16)	-14.25

Milestone Scientific has higher earnings, but lower revenue than Surgalign. Milestone Scientific is trading at a lower price-to-earnings ratio than Surgalign, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Milestone Scientific and Surgalign, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0	1	1	0	2.50
Surgalign	0	0	4	0	3.00

Milestone Scientific currently has a consensus target price of $4.00, suggesting a potential upside of 8.70%. Surgalign has a consensus target price of $4.3333, suggesting a potential upside of 90.06%. Given Surgalign's stronger consensus rating and higher possible upside, analysts clearly believe Surgalign is more favorable than Milestone Scientific.

Summary

Surgalign beats Milestone Scientific on 10 of the 13 factors compared between the two stocks.